Anal fistula
Conditions
Interventions
Test group:Intraoperative management: The patient first underwent classical anal fistula resection. After the operation, the wound was rinsed and sterilized with metronidazole solution and dried with
Control group:Intraoperative management: The patient first underwent classical anal fistula resection. After the operation, the wound was filled with dressing and bandaged, and the dressing was covere
Sponsors
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients with adenogenous anal fistula with imaging examination(MRI) consistent with the intersphincteric and transsphincteric types of Park's classification, with a single and straight fistula with an external opening of less than 5 cm in length from the anal verge; 2. The fistula is in the stable stage; 3.There is no contraindication to surgery, and it is proposed to perform classical anal fistula resection in the Department of Proctology of Yueyang Hospital; 4. Age = 18 years and = 65 years, gender is not limited; 5. Understand and agree to participate in this study, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients with a combined history of other anorectal diseases or a history of surgery (including colorectal malignancy, Crohn's disease, ulcerative colitis, intestinal tuberculosis, etc.). 2. Patients with contraindications to surgery (e.g. those with hematopoietic and coagulation disorders, patients in pregnancy or lactation); 3.Those with serious heart, liver, kidney, lung insufficiency and other diseases; 4.Those with a history of uncontrollable psychosis; 5. Subjects with uncontrolled diabetes or diseases or conditions known to affect the wound healing process; 6. Persons with a known allergy to the components of this medical bioadhesive. 7. Subjects who require additional use of drugs or devices that affect wound healing, such as topical growth factors, in the test area; 8.Have participated or are participating in other clinical studies in the last 3 months; 9.Any medical history that, in the judgment of the investigator, is likely to interfere with the results of the trial or increase the risk to the patient.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cure rate of wound healing at 18 days postoperatively; | — |
Secondary
| Measure | Time frame |
|---|---|
| Wound healing time;Postoperative pain;Postoperative wound edema;Skin allergy;Wound infection; | — |
Countries
China
Contacts
Public ContactHan Changpeng
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed